EUVIMEDEUVIMED entdecken
Crossref

Discovery of novel benzomorpholine derivatives as potent URAT1 inhibitors with hypouricemic effects

Yongcheng Wang, Lei Zhang, Mengjie Shao, Xianxin Hou, Ying Yang, Yifan Yang, Fei Ye, Xuechen Li, Zhiyan Xiao

Bioorganic & Medicinal Chemistry Letters · 2025

DOI: 10.1016/j.bmcl.2025.130342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2025. Verfasst von Yongcheng Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Active Substance Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences an…. Hauptthemen laut MEDLINE: Organic Cation Transport Proteins, Organic Anion Transporters, Hyperuricemia, Drug Discovery. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chinese Academy of Medical Sciences Initiative for Innovative Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urate transporter 1 (URAT1) is a clinically validated therapeutic target for hyperuricemia and gout. To obtain structurally novel URAT1 inhibitors, a series of benzomorpholine derivatives were designed by adopting a pharmacophore guided molecular hybridization strategy. Most compounds potently inhibit the human URAT1 in HEK293 cells, and the most active compound 7 exhibited an IC50 of 0.72 μM, which was much more potent than Lesinurad and comparable to Benzbromarone. The possible interaction mode of compound 7 with URAT1 was revealed by molecular modeling. Cell viability assays indicated that compound 7 was less cytotoxic than Benzbromarone in Hep-G2 cells. The urate-lowering effects of compounds 1 and 7 were confirmed in two different hyperuricemia mouse models, and no obvious toxicity was observed in the treated mice. The results provide new chemical prototypes for urate-lowering drug discovery targeting URAT1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Organic Cation Transport ProteinsOrganic Anion TransportersHyperuricemiaDrug DiscoveryMorpholinesHumansAnimalsMiceStructure-Activity RelationshipHEK293 CellsMolecular StructureHep G2 CellsCell SurvivalDose-Response Relationship, Drug

Stichwörter der Autor:innen

Benzomorpholine scaffoldGoutHyperuricemiaHypouricemic efficacyURAT1 inhibitor

Substanzen

SLC22A12 protein, humanOrganic Cation Transport ProteinsOrganic Anion TransportersMorpholines

Autor:innen und Institutionen

  • Beijing Key Laboratory of Active Substance Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
  • Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
  • Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. Electronic ad…
  • Beijing Key Laboratory of Active Substance Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China; State Key Labor…

Förderung

  • National Natural Science Foundation of China
  • Chinese Academy of Medical Sciences Initiative for Innovative Medicine

Zitieren

APA

Wang, Y., Zhang, L., Shao, M., Hou, X., Yang, Y., Yang, Y., Ye, F., Li, X., & Xiao, Z. (2025). Discovery of novel benzomorpholine derivatives as potent URAT1 inhibitors with hypouricemic effects. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2025.130342

Vancouver

Wang Y, Zhang L, Shao M, Hou X, Yang Y, Yang Y, et al. Discovery of novel benzomorpholine derivatives as potent URAT1 inhibitors with hypouricemic effects. Bioorganic & Medicinal Chemistry Letters. 2025. doi:10.1016/j.bmcl.2025.130342

BibTeX
@article{Wang2025,
  author = {Wang, Yongcheng and Zhang, Lei and Shao, Mengjie and Hou, Xianxin and Yang, Ying and Yang, Yifan and Ye, Fei and Li, Xuechen and Xiao, Zhiyan},
  title = {Discovery of novel benzomorpholine derivatives as potent URAT1 inhibitors with hypouricemic effects},
  journal = {Bioorganic & Medicinal Chemistry Letters},
  year = {2025},
  doi = {10.1016/j.bmcl.2025.130342}
}
Kostenlos starten →